NEW YORK, NY / ACCESS Newswire / November 13, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding MoonLake Immunotherapeutics (NASDAQ:MLTX) class action securities lawsuit A Class Action lawsuit was filed on behalf of MoonLake Immunotherapeutics investors who lost money as a result of alleged securities fraud between March 10, 2024 and September 29, […]
Sanya, China: Building a Global Hub for Deep-Sea Technology Research and International Exchange GlobeNewswire November 13, 2025 SANYA, China, Nov. 13, 2025 (GLOBE NEWSWIRE) — Recently, the 3rd Hainan Free Trade Port International Science and Technology Innovation Cooperation Forum (ISTICF) & Deep-Sea Technology Innovation Conference (DSTIC) concluded successfully at the Deep-Sea Science and Technology Innovation
(AUST:ARR.AX),(OTC US:AMRRY),(OTCQX:AMRRY),(Boerse Frankfurt – Freiverkehr:1BHA),(OTC US:ARRNF),(Other OTC:ARRNF), DENVER, Nov. 13, 2025 (GLOBE NEWSWIRE) — Dear Shareholders, On behalf of the Board, I am pleased to present my address to shareholders for the 2025 Annual General Meeting at a pivotal moment for the Company and the U.S. rare earths industry. Heightened geopolitical tensions and recent restrictions
(NASDAQ:VANI), Company plans to initiate Phase 1 clinical study of semaglutide implant for chronic weight management in the first half of 2026 and parallel investments in studies to enable rapid initiation of Phase 2 dose-ranging study, pending Phase 1 results and regulatory feedback 3Q 2025 private placement, together with October financings, generated approximately $25.7M in
(NASDAQ:IMNN), R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advanced ovarian cancer Company to hold conference call today at 11:00 a.m. ET LAWRENCEVILLE, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) — IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company
Probiotics Animal Feed Market Set to reach USD 11.72 Billion by 2034, Driven by the Shift Toward Antibiotic-Free Livestock Nutrition According to Towards FnB, the global probiotics animal feed market size is evaluated at USD 5.44 billion in 2025 and is anticipated to hit USD 11.72 billion by 2034. This sustained rise represents an impressive
2025 AGM Chairman's Address American Rare Earths' Flagship Halleck Creek Project is the fast-track development to secure a long-term supply of U.S. magnet metals for national security, defence, and manufacturing GlobeNewswire November 13, 2025 DENVER, Nov. 13, 2025 (GLOBE NEWSWIRE) — Dear Shareholders, On behalf of the Board, I am pleased to present my address
Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results GlobeNewswire November 13, 2025 Company plans to initiate Phase 1 clinical study of semaglutide implant for chronic weight management in the first half of 2026 and parallel investments in studies to enable rapid initiation of Phase 2 dose-ranging study, pending Phase 1 results
IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update GlobeNewswire November 13, 2025 R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advanced ovarian cancer Company to hold conference call today at 11:00 a.m. ET LAWRENCEVILLE,
NEW YORK, NY / ACCESS Newswire / November 13, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding aTyr Pharma, Inc. (NASDAQ:ATYR) class action securities lawsuit A Class Action lawsuit was filed on behalf of aTyr Pharma, Inc. investors who lost money as a result of alleged securities fraud between November 7, 2024 and